Written by:
Dr. Sophie Reynolds
Dr. Sophie Reynolds is a board-certified medical doctor specializing in internal medicine. With over a decade of experience in patient care and medical writing
Xtane 25 mg Tablet
Please fill in the details below, and we’ll get back to you as soon as possible
Similar Products:
| Image | Product | Manufacturer / Marketed By | Price |
|---|---|---|---|
![]() | Aromasin 25 mg Tablet | Pfizer | Ask for Price |
Description
Xtane 25mg Tablet contains Exemestane, a hormonal therapy used to treat hormone receptor–positive breast cancer in postmenopausal women. It lowers estrogen levels to help slow or stop cancer growth under oncologist supervision.
Benefits
-
Reduces estrogen-driven cancer growth
-
Lowers risk of breast cancer recurrence
-
Proven survival and disease-control benefits
-
Convenient once-daily oral therapy
-
Well-established hormonal treatment option
Indications and Usage
Xtane 25mg Tablet is indicated for:
-
Hormone receptor–positive (HR+) breast cancer
-
Postmenopausal women
-
Adjuvant therapy following tamoxifen treatment
-
Advanced or metastatic breast cancer, if disease has progressed
Treatment must be prescribed and monitored by a cancer specialist.
How it Works
Exemestane blocks the aromatase enzyme, responsible for estrogen production in postmenopausal women. Lower estrogen levels deprive HR-positive cancer cells of the hormone they need to grow, helping slow or stop tumor progression.
Dosage & Administration
-
Usual dose: 25 mg once daily, or as prescribed
-
Take after a meal, at the same time each day
-
Swallow tablet whole with water
-
Do not skip or stop treatment without medical advice
-
Regular monitoring of bone density, liver function, and treatment response required
Side Effects
Common side effects:
-
Hot flashes
-
Fatigue
-
Joint or muscle pain
-
Headache
-
Sweating
-
Nausea
Serious side effects (seek medical care):
-
Severe bone thinning (osteoporosis)
-
Depression or mood changes
-
Liver problems
-
Severe allergic reactions
Warning and Precaution
-
Not recommended in pregnancy or breastfeeding
-
For postmenopausal women only, unless directed by oncologist
-
Use cautiously in patients with osteoporosis or vitamin D deficiency
-
Avoid alcohol and smoking to protect bone health
-
Inform doctor about ongoing medications, especially hormonal therapy
-
Report severe bone pain, jaundice, swelling, or breathing difficulty immediately
Related Products
Related Posts:
Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another
READ MORE »Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026.n n This marks an important
READ MORE »FDA Approves Vepdegestrant for ER+/HER2–, ESR1-Mutated Breast Cancer: A New Targeted Option
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 6, 2026. Breast cancer treatment continues to evolve
READ MORE »Only logged in customers who have purchased this product may leave a review.


Reviews
Clear filtersThere are no reviews yet.